Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Scottish Hospital Endowments Research Trust | OTHER |
| Pacla Medical Limited | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The objective of the study is to measure the effect of a spinal mobilisation intervention on para-spinal muscle tissue quality, functional balance measures, pain and fatigue in people with multiple sclerosis. The mobilisation intervention group will be compared to a general massage group to analyse the difference between the specificities of the intervention compared to general manual touch. Participants will be randomly allocated to a group condition for a between-subject, repeated measures study. The study hypothesises a decrease in lumbar stiffness, body sway, pain and fatigue post the intervention compared to the general massage group.
The long term management of multiple sclerosis (MS) symptoms may often involve manual therapeutics due to observed improvements in muscle stiffness, pain, fatigue and balance. Though these improvements are often anecdotal without objective measurement and without analysis of the manual therapeutic. This is partly due to the vast array of manual therapeutics available as well as the many possible influencing factors contributing to these symptoms.
The objective of this study is to measure and analyse the cumulative effect of a spinal mobilisation intervention on muscle tissue quality, functional balance, pain and fatigue in people with MS. The intervention will be analysed at a specific rate, pressure and location and compared to a general manual touch session with no specificities on rate, pressure or location. Both therapy sessions will be 30 minutes long. The force of both therapy sessions will be recorded in real time by monitoring the vertical ground reaction force (GRF) profile using 2 Kistler force plates placed underneath the treatment plinth. A 0 force will be generated once each participant is lying supine and still on the plinth and recordings will be taken in 30 second samples during the treatment sessions. The summation of the vertical GRFs will be graphed and monitored to check consistency of the treatment force. The mobilisation intervention will be given at a rate of 0.37Hz (22 beats per minute) maintained by a metronome on silent within view of the therapist, the pressure will be maintained at a pressure grade of less than 1 (equal to a threshold of 80N), and maintained consistent physical contact on paraspinal region within L1-L5. The general massage will be applied on the mid-lower back, with no specificities or consistencies; physical contact, rate and force magnitude will not be kept constant. This will be tested on 20 participants with MS who are randomly allocated to a group condition for a between-subject, repeated measures study.
Participants will be randomly allocated to either an intervention or general massage group for which they will attend 4 separate therapy sessions. During the 1st session, the participants will carry out tests for lumbar muscle response, measured stiffness, tone and elasticity (using MyotonPro), functional balance measures in a single-leg balance and sit-to-stand tests (using Kistler force plates), self-reported pain and self-reported fatigue for pre and post treatment sessions. During the subsequent 3 sessions, the participants will complete tests for the myometer, balance and pain post the treatment sessions, and the final fatigue test will be completed after their last session. Participants will therefore complete 5 set of tests for the myometer, balance and pain and the fatigue test is completed pre and post all therapy sessions due to the set-up of the questionnaire.
Participants will complete an online questionnaire before their 1st to screen for eligibility criteria and collect anthropometric details and information on their MS condition. This will be analysed with the results into descriptive statistics and summarised into mean, range and dispersion values. All dependent variables measured for muscle tissue response, functional balance, pain and fatigue will be analysed in between-subject repeated measured ANOVA to determine differences between the 2 treatment groups and between the different treatment time points. Pearson correlations will be carried out on the myometer variables to compare the baseline values to the level of change after their final session due to previously found significant correlations.
More participants were intended for recruitment in the study, a post-hoc power calculation revealed a power of 0.9 with an alpha level at 0.05 with a range of large effect sizes in the results.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental A - Mobilisation Intervention | Experimental | Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention. |
|
| Experimental B - General Massage | Active Comparator | Participants receive 4 separate treatment sessions of the 30 minute general massage. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Spinal Mobilisation Intervention | Other | 30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Taken at baseline, pre-treatment. |
| Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. |
| Measure | Description | Time Frame |
|---|---|---|
| Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Respond positively to any absolute contraindications for spinal manual therapy including:
Respond positively to any relative contraindications for spinal manual therapy including:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Edinburgh Napier University | Edinburgh | County | EH11 4BN | United Kingdom |
Anonymised participant data sets that underlie the results for publication will be shared on a raw data set. This includes the anthropometric data, MS information data, myometer data, functional balance data, pain and fatigue data.
The data will be entered when the study is completed and remain until 1 year post publication of summary data.
the anonymised participant data underlying the summary data published will be shared on the Edinburgh Napier University University Repository with submission of PhD thesis.
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Experimental A - Mobilisation Intervention | Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention. Spinal Mobilisation Intervention: 30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5. |
| FG001 | Experimental B - General Massage | Participants receive 4 separate treatment sessions of the 30 minute general massage. General Massage: 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Experimental A - Mobilisation Intervention | Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention. Spinal Mobilisation Intervention: 30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5. |
| BG001 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Newton-metres | Taken at baseline, pre-treatment. |
|
4 testing sessions lasting 2 hours each, one week apart each time, lasting a total of 8 hours within a 3 week period.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Experimental A - Mobilisation Intervention | Participants receive 4 separate treatment sessions of the 30 minute spinal mobilisation intervention. Spinal Mobilisation Intervention: 30 minutes spinal mobilisations, rate = 0.37Hz, 22 beats per minute, force = less than grade 1, threshold of 80N, location = L1-L5. |
Not provided
Not provided
Study was not able to recruit full number of participants required in the sample size calculation and large degree of variability exists within the population.
A longer term study with more treatment sessions may show more cumulative effect within the data results.
The study used an alternative treatment for group comparison rather than placebo for ethical and feasibility reasons.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr Rebecca Hamilton | Edinburgh Napier University | 0131455 | 2350 | rebeccaisabel.hamilton@napier.ac.uk |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Oct 1, 2018 | Jun 5, 2022 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D005221 | Fatigue |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Mixed factor: between-subject, repeated measures (mobilisation intervention vs general massage).
Not provided
Not provided
Not provided
Not provided
| General Massage | Other | 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch. |
|
| Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Taken at baseline, pre-treatment. |
| Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Taken at baseline, pre-treatment. |
| Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale. | Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue. | Taken at baseline, pre-treatment. |
| Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale. | Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Taken at baseline, pre-treatment. |
| Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Taken at baseline, pre-treatment. |
| Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Taken at baseline, pre-treatment. |
| Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
| Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
| Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
| Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
| Experimental B - General Massage |
Participants receive 4 separate treatment sessions of the 30 minute general massage. General Massage: 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Height (m) | Mean | Standard Deviation | meters |
|
| Mass (kg) | Mean | Standard Deviation | Kilograms |
|
| Body Mass Index | Mean | Standard Deviation | Kilograms/meters^2 |
|
| Expanded Disability Status Scale | Self-reported by participant using pre-screening online survey based on disabilities associated with multiple sclerosis. Scale ranges from 0-10 in 0.5 increments each representing a higher level of disability. 0 represents no disability, 1-4.5 represents people who are able to walk without an aid, 5-9.5 represents more severly disabled and impairment to walking and 10 represents death due to multiple sclerosis complications. | Mean | Standard Deviation | Units on a scale |
|
| OG001 | Experimental B - General Massage | Participants receive 4 separate treatment sessions of the 30 minute general massage. General Massage: 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch. |
|
|
| Primary | Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Newton-metres | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Primary | Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Newton-metres | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Primary | Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Newton-metres | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Primary | Participant Muscle Stiffness Measure | Myometer measured stiffness taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given in Newton-metre units. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Newton-metres | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Primary | Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken at baseline, pre-treatment. |
|
|
|
| Primary | Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Primary | Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Primary | Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Primary | Participant Single Leg Stance Body Sway Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Primary | Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Posted | Mean | Standard Error | Millimeters/second | Taken at baseline, pre-treatment. |
|
|
|
| Primary | Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Primary | Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Primary | Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Primary | Participant Sit-to-Stand Velocity | Force plate recording from sit-to-stand test. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Primary | Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Posted | Mean | Standard Error | Units on a scale | Taken at baseline, pre-treatment. |
|
|
|
| Primary | Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Posted | Mean | Standard Error | Units on a scale | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Primary | Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Posted | Mean | Standard Error | Units on a scale | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Primary | Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Posted | Mean | Standard Error | Units on a scale | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Primary | Participant Pain Score - Visual Analogue Scale (VAS) | Self-reported pain score annotated by participant pointing on the VAS sheet. Score is between 0-10 with 0 as lowest pain score and 10 as highest pain score. | Posted | Mean | Standard Error | Units on a scale | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Primary | Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale. | Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue. | Posted | Mean | Standard Error | Units on a scale | Taken at baseline, pre-treatment. |
|
|
|
| Primary | Participant Fatigue Score - 5 Item Modified Fatigue Impact Scale. | Self-reported fatigue score from filling out 5 questions on the fatigue questionnaire with possible answers ranging from 0-4. 0 representing 'never experienced' and 4 representing 'almost always experienced'. Total score ranges between 0-20 with 0 representing never experiencing fatigue and 20 representing almost always experiencing fatigue. | Posted | Mean | Standard Error | Units on a scale | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Hertz | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Hertz | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Hertz | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Hertz | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Muscle Tone Measure | Myometer measured muscle tone taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as a frequency measure in Hertz. Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Hertz | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Natural log of acceleration peak ratio | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Natural log of acceleration peak ratio | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Natural log of acceleration peak ratio | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Natural log of acceleration peak ratio | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Muscle Elasticity Measure | Myometer measured muscle elasticity taken from Erector Spinae muscle central belly via accelerometer probe registering response from a series of low force mechanical impulses applied perpendicular to the muscle. The muscle central belly was palpated while asking the participant to lift their head and feet at the same time while lying in prone position contracting this muscle. Measurements taken from a myometer device given as the logarithmic decrement of tissue's natural dampening frequency oscillation characterising its elasticity (dissipation of mechanical energy). Further method details are given in the Protocol Document in attachments. | Posted | Mean | Standard Error | Natural log of acceleration peak ratio | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Anterior-Posterior Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Anterior-Posterior position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Medial-Lateral Path Length | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position body sway travelled in the Medial-Lateral position. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters/second | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Single Leg Stance Body Sway Velocity | Force plate recording from single leg stance balance test automatically outputted by software using centre of pressure recording to track position total body sway velocity travelled. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Millimeters/second | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Percentage of Body Weight | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Percentage of Body Weight | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Percentage of Body Weight | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Percentage of Body Weight | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Sit-to-Stand Rising Index | Force plate recording from sit-to-stand test automatically outputted by software using percentage of body weight applied to the force plate during the stance phase of movement. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Percentage of Body Weight | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| Secondary | Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Seconds | Taken at baseline, pre-treatment. |
|
|
|
| Secondary | Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Seconds | Taken immediately post 1st treatment, same day as baseline measures (week 1). |
|
|
|
| Secondary | Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Seconds | Taken immediately post 2nd treatment, 1 week after baseline measurements (week 2). |
|
|
|
| Secondary | Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Seconds | Taken immediately post 3rd treatment, 2 weeks after baseline measurements (week 3). |
|
|
|
| Secondary | Participant Sit-to-Stand Weight Transfer | Force plate recording from sit-to-stand test automatically outputted by software using the time taken to reach full standing recorded by the force plate. Further details are outlined in the attached Protocol Document. | Posted | Mean | Standard Error | Seconds | Taken immediately post 4th treatment, 3 weeks after baseline measurements (week 4). |
|
|
|
|
| 0 |
| 10 |
| 0 |
| 10 |
| 0 |
| 10 |
| EG001 | Experimental B - General Massage | Participants receive 4 separate treatment sessions of the 30 minute general massage. General Massage: 30 minutes manual touch with no specifications or recordings on rate, pressure or location of touch. | 0 | 10 | 0 | 10 | 0 | 10 |
Not provided
Not provided
Not provided
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Stiffness values were analysed as a percentage change from baseline measurements to normalise group variances. |
| ANOVA |
Repeated measures ANOVA including all 5 time points in the analysis. |
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| < 0.05 |
Including partial eta squared large effect size. |
| Superiority |
Sit-to-stand velocity values were analysed as a percentage change from baseline measurements to normalise group variances. |
| ANOVA |
Repeated measures ANOVA including all 5 time points in the analysis. |
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including both time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Muscle tone values were analysed as a percentage change from baseline measurements to normalise group variances. |
| ANOVA |
Repeated measures ANOVA including all 5 time points in the analysis. |
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| < 0.05 |
Including partial eta squared large effect size. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| > 0.05 |
A priori threshold for statistical significance is 0.05. |
| Superiority |
Repeated measures ANOVA including all 5 time points in the analysis.
| < 0.05 |
Including partial eta squared large effect size. |
| Superiority |